Cytology is the study of cells using a microscope.
Ninety-nine percent of cervical cancers are caused by human papillomavirus (HPV). More than 200 HPVs, some of which are associated with varying degrees of cancer risk, complicate diagnosis and treatment.
This non-invasive diagnostic method could help detect the disease in its earliest stages with a small urine sample.
The prevalence of anal high-grade squamous intraepithelial lesions (HSIL), which precede anal cancer, is much higher in women living with HIV than previously reported, a multi-site, national study involving hundreds of patients has found.
BD, a leading global medical technology company, today announced the CE-IVDD certification of the BD COR System in Europe.
The use of molecular biomarkers in minimally invasive sampling opens a promising perspective for the early detection of endometrial cancer.
Immune checkpoint inhibitors, such as the anti-PD-1 antibody pembrolizumab, have become important tools for managing non-small-cell lung cancer.
An interview with Professor Attila Lorincz, discussing the development of a new cervical cancer test that is able to predict cervical cancer and pre-cancer in 100% cases.
Russian neuroscientists discovered that the stress experienced by mice during their first weeks of life, affects not only them but also their offspring. The obtained data will help to understand how negative experience in the early period of life affects the mammalian brain.
Researchers have uncovered an increased risk of cervical cancer in women whose cervical cells test positive for certain high-risk human papillomavirus types but do not show any signs of cellular abnormalities.
In low-resource countries without well-developed screening programs, expanding access to human papilloma virus vaccination is the best means of preventing cervical cancer and other diseases caused by HPV infection, according to an editorial in the October special issue of the Journal of Lower Genital Tract Disease, official journal of ASCCP.
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
The United States Preventive Services Task Force has released new recommendations on screening for cervical cancer.
According to health advisors from the U.S. Preventive Services Task Force, Pap smears may not be the only way to check for cervical cancer risk among women.
A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.
Tissue engineering is the future of medicine. Under Project 5-100, the Polymer Materials for Tissue Engineering and Transplantology Laboratory of Peter the Great St. Petersburg Polytechnic University created unique polymeric materials for medical purposes that repair traumatized human organs.
Nucleix Ltd., a leading cancer detection and screening company, announced today that the multi-center European study results with its Bladder EpiCheck urine test for the detection of bladder cancer recurrence, were published in the European Urology Oncology journal.
The Pap smear test has been used widely for the past five decades to understand and screen for early signs of cervical cancer. The conventional test has been largely replaced by a liquid-based Pap cytology test. Soon it may be replaced by another test – the Human papilloma virus test or the HPV test finds new research.
A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that high-quality cervical cancer screening can be done effectively using a completely automated approach. The researchers involved in the study indicate that automated technology could increase cervical screening coverage in underserved regions.
Urothelial cancers of the bladder and upper urinary tract are among the most common cancers encountered worldwide. In the United States, urothelial cancers are among the most costly cancers to treat.
A new test for urothelial cancers could detect mutations in DNA that have been identified for those cancers earlier than traditional tests. The earlier detection of urothelial cancer could lead to earlier treatment, and potentially better outcomes for patients.